BNTX BioNTech SE Stock Quote

BNTX [NASD]

Index	-	P/E	-	EPS (ttm)	-	Insider Own	1.18%	Shs Outstand	238.67M	Perf Week	1.20%
Market Cap	25.49B	Forward P/E	5.70	EPS next Y	17.83	Insider Trans	0.00%	Shs Float	223.06M	Perf Month	-8.64%
Income	-	PEG	-	EPS next Q	0.17	Inst Own	10.60%	Short Float	2.64%	Perf Quarter	12.40%
Sales	-	P/S	-	EPS this Y	-300.50%	Inst Trans	0.73%	Short Ratio	1.44	Perf Half Y	19.17%
Book/sh	4.72	P/B	21.52	EPS next Y	1280.10%	ROA	-	Target Price	118.06	Perf Year	215.01%
Cash/sh	4.89	P/C	20.79	EPS next 5Y	-	ROE	-	52W Range	28.00 - 131.00	Perf YTD	24.62%
Dividend	-	P/FCF	-	EPS past 5Y	-	ROI	-31.40%	52W High	-21.94%	Beta	-
Dividend %	-	Quick Ratio	4.00	Sales past 5Y	-	Gross Margin	-	52W Low	265.23%	ATR	6.89
Employees	1800	Current Ratio	4.10	Sales Q/Q	-47.10%	Oper. Margin	-	RSI (14)	51.58	Volatility	5.95% 6.28%
Optionable	Yes	Debt/Eq	0.34	EPS Q/Q	-314.60%	Profit Margin	-	Rel Volume	0.55	Prev Close	101.59
Shortable	Yes	LT Debt/Eq	0.19	Earnings	Nov 10 BMO	Payout	-	Avg Volume	4.08M	Price	102.26
Recom	2.20	SMA20	5.50%	SMA50	-1.59%	SMA200	36.81%	Volume	909,748	Change	0.66%

Dec-01-20

Downgrade

BofA Securities

Buy → Neutral

$123 → $126

Aug-03-20

Resumed

Berenberg

Buy

$98

Jul-21-20

Upgrade

BofA Securities

Neutral → Buy

$71 → $105

Jun-30-20

Downgrade

H.C. Wainwright

Buy → Neutral

May-19-20

Upgrade

H.C. Wainwright

Neutral → Buy

$48 → $69

Apr-28-20

Downgrade

BofA/Merrill

Buy → Neutral

$46 → $51

Mar-18-20

Downgrade

JP Morgan

Overweight → Neutral

$23 → $33

Mar-09-20

Initiated

H.C. Wainwright

Neutral

$30

Jan-24-20

Downgrade

SVB Leerink

Outperform → Mkt Perform

Jan-22-20

Downgrade

UBS

Buy → Neutral

$35

Nov-05-19

Initiated

Wolfe Research

Outperform

Nov-04-19

Initiated

UBS

Buy

$21

Nov-04-19

Initiated

SVB Leerink

Outperform

Nov-04-19

Initiated

JP Morgan

Overweight

$23

Nov-04-19

Initiated

Canaccord Genuity

Buy

$22

Nov-04-19

Initiated

BofA/Merrill

Buy

$21

Nov-04-19

Initiated

Berenberg

Buy

$25

Jan-19-21 07:46AM	European countries struggle to make most of Pfizer COVID-19 vaccine doses Reuters
Jan-18-21 11:34AM	Israel sharing COVID-19 data with Pfizer to help fine-tune vaccine rollout Reuters
08:46AM	Norway advises caution in use of Pfizer vaccine for the most frail Reuters
Jan-17-21 07:02AM	Lebanon inks final deal for 2.1 mln doses of Pfizer-BioNTech vaccine Reuters
Jan-16-21 02:55AM	Pfizer delays Jan. vaccine delivery to Bahrain - health ministry Reuters
Jan-15-21 01:46PM	Why Pfizer Is a Long-Term Investors Friend InvestorPlace
10:55AM	Pfizer Slows Non-U.S. Vaccine Deliveries Amid Manufacturing Changes; Boosts 2021 Dose Goal to 2 Billion TheStreet.com
10:51AM	Is Novavax Stock A Buy As Pressure Mounts For A Covid-19 Vaccine? Investor's Business Daily
10:11AM	Coronavirus update: Biden calls for 100 million vaccinations, $121 billion for health care to fight COVID-19 Yahoo Finance
09:43AM	Lebanese parliament approves law paving way for vaccine deal Reuters
Jan-14-21 04:55PM	Pfizer Leads Vaccine Stocks As The Most Trusted Name In Covid-19: IBD/TIPP Investor's Business Daily
03:31PM	Covid-19 Infection Likely to Provide Immunity for at Least Five Months, Study Finds. What That Might Mean. Barrons.com
06:41AM	COVID-19 infection likely to provide immunity for at least 5 months, but people may still transmit virus, study finds MarketWatch
Jan-13-21 05:44PM	J&J Stock Pops After Midstage Test Shows Its Covid Vaccine Is Durable Investor's Business Daily
01:02PM	How the government is handling the COVID-19 vaccine rollout, Biden admin. outlook Yahoo Finance Video
12:48PM	J&J Stock Dips On Report Its Covid Vaccine Is 2 Months Behind Schedule Investor's Business Daily
05:45AM	Baxter Germany to start production of BioNTech/Pfizer vaccine by early March Reuters
Jan-12-21 11:05PM	Analysts Just Published A Bright New Outlook For BioNTech SE's (NASDAQ:BNTX) Simply Wall St.
04:29PM	Pfizer Skids To 200-Day Line On Earnings Outlook That Lagged Some Views Investor's Business Daily
01:16PM	A Guide to Biotech ETF Investing Amid the Coronavirus Crisis Zacks
01:02PM	Pfizer Says It Can Quickly Develop Vaccines for Future Covid-19 Variants Barrons.com
11:03AM	AstraZenecaOxford COVID-19 shot could be authorized Jan. 29, says EU medical regulator MarketWatch
10:37AM	COVID-19 Vaccine Production to Ramp Up Zacks
10:22AM	Covid-19 Vaccinations Promise to Ramp Up Zacks
09:57AM	Pfizer has produced more than 70 mln COVID-19 vaccine doses-CEO Reuters
09:18AM	Moderna (MRNA) Stock Up on Vaccine Pipeline Expansion Plan Zacks
08:16AM	Uber, Moderna to collaborate on supporting COVID-19 vaccine uptake MarketWatch
08:00AM	Uber and Moderna Team Up to Boost Vaccine Awareness Bloomberg
07:15AM	Is AstraZeneca Stock A Buy After Coronavirus Vaccine Gains U.K. Nod? Investor's Business Daily
06:05AM	2021's buzziest phrase has already been a winner Yahoo Finance
Jan-11-21 06:04PM	Why BioNTech Crushed the Market on Monday Motley Fool +8.48%
04:34PM	BioNTech Surges On Its Plan To Make 2 Billion Covid Vaccine Doses In 2021 Investor's Business Daily
02:03PM	BioNTech to offer vaccine to its own workers Reuters
12:29PM	BioNTech CEO Says a Version of Its Covid Vaccine With Less Stringent Storage Requirements Could Come This Year Barrons.com
01:00AM	CORRECTED-RPT-Scarce doses and empty vaccination centres: Germany's vaccine rollout headache Reuters
Jan-10-21 11:25PM	Malaysia buys additional 12.2 million doses of Pfizer-BioNTech COVID-19 vaccine Reuters
07:00AM	CORRECTED-Scarce doses and empty vaccination centres: Germany's vaccine rollout headache Reuters
Jan-09-21 01:00AM	mRNA Vaccines Could Vanquish Covid Today, Cancer Tomorrow Bloomberg
Jan-08-21 04:32PM	BioNTech Jumps As Study Suggests Covid Vaccine Might Block New Strains Investor's Business Daily +7.15%
03:37PM	COVID SCIENCE-Pfizer/BioNTech vaccine works against virus variants in lab; arthritis drugs improve COVID-19 survival Reuters
03:14PM	Biden plans to distribute COVID-19 vaccine doses immediately MarketWatch
01:23PM	20 Biggest Questions in Science Insider Monkey
12:59PM	Coronavirus update: Pfizer says vaccine may work against UK and South Africa strains; vaccinations to increase under Biden administration Yahoo Finance
12:29PM	Modernas COVID-19 vaccine becomes third shot authorized for use in U.K. MarketWatch
10:55AM	FDA Commissioner Says States Should Expand Covid-19 Vaccine Eligibility Barrons.com
10:41AM	As Competition Rises, the Bull Case for Moderna Stock Is Beginning to Fade InvestorPlace
10:00AM	Dow Jones Today, Stocks Jump Despite Payrolls Miss; Bitcoin Tops $41,000, Micron Earnings Beat Investor's Business Daily
09:47AM	Germany secured 50 mln vaccine doses from CureVac, BioNTech on top of EU supplies - document Reuters
09:00AM	Don't Expect Covid-19 Research to Deliver Certainty Bloomberg
08:47AM	PfizerBioNTech vaccine appears to protect against U.K. and South African COVID-19 strains in lab, study finds MarketWatch
08:28AM	Europe's drug regulator says there is an extra dose in BioNTech/Pfizer's COVID-19 vaccine vials MarketWatch
08:26AM	Moderna's COVID-19 vaccine becomes third to be authorized by U.K. regulator MarketWatch
08:23AM	Pfizer Research Suggests Covid-19 Vaccine Will Protect Against New Variants Barrons.com
08:07AM	Dow Jones Today, Futures Up, Payrolls Data Pending; Bitcoin Tops $41,0000, Micron Earnings Beat Investor's Business Daily
06:45AM	Pfizer and BioNTech say COVID-19 vaccine neutralizes mutation found in new U.K., South Africa variants MarketWatch
05:45AM	An In Vitro Study Shows Pfizer-BioNTech COVID-19 Vaccine Elicits Antibodies that Neutralize SARS-CoV-2 with a Mutation Associated with Rapid Transmission GlobeNewswire
Jan-07-21 10:21PM	Pfizer/BioNTech vaccine appears effective against mutation in new coronavirus variants -study Reuters
04:32PM	This Covid Vaccine Stock Just Rocketed On A Deal With Pharma Giant Bayer Investor's Business Daily
02:15PM	BioNTech Publishes Data on Novel mRNA Vaccine Approach to Treat Autoimmune Diseases in Science GlobeNewswire
10:20AM	The Zacks Analyst Blog Highlights: Pfizer, BioNTech, Moderna and AstraZeneca Zacks
09:25AM	Moderna (MRNA) COVID-19 Vaccine Gets Authorization in Europe Zacks
08:39AM	Third vaccine could be authorized for U.K. within weeks, boosting mass immunization drive, top scientist says MarketWatch
Jan-06-21 08:33PM	Debate Over Electoral Votes Resumes; Twitter Suspends Trump Account Barrons.com +5.05%
04:16PM	Moderna Stock Gains After European Agency Recommends Covid Vaccine Investor's Business Daily
01:00PM	U.S. officials report more severe allergic reactions to COVID-19 vaccines Reuters
12:09PM	5 reasons musicians like Bob Dylan, Neil Young and Stevie Nicks are selling their song catalogs right now MarketWatch
09:32AM	FDA Opposes Dilution of COVID-19 Vaccine Doses: Here's Why Zacks
09:25AM	Slow vaccine rollout stokes tensions among EU states Reuters
06:31AM	WRAPUP 3-Moderna COVID-19 vaccine gets the green light in Europe Reuters
Jan-05-21 07:50PM	Colombia regulator approves Pfizer-BioNTech vaccine for emergency use Reuters
02:19PM	Coronavirus update: WHO and FDA differ on changes to COVID-19 vaccine dosing Yahoo Finance
01:48PM	Merkel Tightens German Lockdown in Push to Contain Outbreak Bloomberg
01:19PM	UK scientists question COVID-19 vaccine dosing delay Reuters
11:37AM	EU In Talks To Buy Up To 300M More Coronavirus Vaccine Doses From Pfizer-BioNTech Benzinga
11:00AM	EU seeks up to 100 mln more doses of Pfizer vaccine in new deal - sources Reuters
10:42AM	Pfizer Drops the Big Blue Pill to Highlight Shift in Strategy Barrons.com
10:33AM	Dutch caught off guard by Pfizer approval, unable to start vaccinations until Weds says PM Reuters
10:15AM	Here's What Investors Need to Know About COVID Vaccines and Allergic Reactions Motley Fool
09:07AM	EU Seeks Up to 300 Million More Pfizer-BioNTech Doses Bloomberg
08:10AM	Why Is Europe Paying a Lot Less Than the U.S. for COVID Vaccines? Motley Fool
06:00AM	BioNTech to Present at the 39th Annual J.P. Morgan Healthcare Conference GlobeNewswire
Jan-04-21 04:19PM	AstraZeneca Pops On U.K. Plans As Covid Vaccine Nabs India Approval Investor's Business Daily +5.16%
12:12PM	Coronavirus update: Moderna raises vaccine production target; new virus strains cause concern Yahoo Finance
11:15AM	Why BioNTech Stock Is Jumping Today Motley Fool
11:02AM	U.K. becomes first country to roll out AstraZeneca-Oxford vaccine as tighter lockdowns imminent MarketWatch
10:18AM	Outlook for biotech companies in 2021 Yahoo Finance Video
10:15AM	3 Takeaways for Investors in mRNA Vaccine Stocks Motley Fool
09:29AM	Germany to Extend Curbs Amid Criticism Over Vaccine Rollout Bloomberg
Jan-03-21 01:35PM	Should Investors Be Worried About Pfizer and BioNTech's Coronavirus Vaccine Rollout? Motley Fool
Jan-02-21 01:42PM	U.K. hits daily coronavirus record, unions urge keeping schools closed MarketWatch
10:49AM	Mexican doctor hospitalized after receiving COVID-19 vaccine Reuters
06:05AM	Pfizer's Next Multibillion-Dollar COVID Vaccine Move Motley Fool
Jan-01-21 06:40PM	Pfizer and BioNTech to offer COVID vaccine to volunteers who got placebo Reuters
04:30AM	BioNTech founders warn of vaccine supply gaps - Spiegel Reuters
Dec-31-20 07:37PM	Pfizer Criticizes Sudden Change in Coronavirus Vaccine Dosing Regime in the U.K. Motley Fool
02:19PM	Why Pfizer is the Cheapest Coronavirus Vaccine Play InvestorPlace
01:34PM	Moderna Stock Is More Than The Covid-19 Vaccine InvestorPlace
Dec-30-20 05:36PM	EXPLAINER-How does AstraZeneca's vaccine compare with Pfizer-BioNTech? Reuters
04:38PM	AstraZeneca Wins U.K. Authorization For Covid Vaccine; Shares Edge Higher Investor's Business Daily
12:04PM	Merck Had a Disappointing 2020. Why Its Strategy Could Pay Off in 2021. Barrons.com

BioNTech SE, a biotechnology company, develops and commercializes immunotherapies for cancer and other infectious diseases. The company is involved in developing FixVac product candidates, including BNT111, which is in Phase I clinical trial for advance melanoma; BNT112 that is in Phase I/II trial for prostate cancer; BNT113, which is in Phase I trial to treat HPV+ head and neck cancers; BNT114 that is in Phase I clinical trial for triple negative breast cancer; BNT115 in a Phase I trial in ovarian cancer; and BNT116, which is in preclinical trail for non-small cell lung cancer. It also develops neo-antigen specific immunotherapies, such as RO7198457, which is in Phase II clinical trial for first-line melanoma, as well as in Phase I clinical trial to treat multiple solid tumors; mRNA intratumoral immunotherapy comprising SAR441000 that is in Phase I clinical trial for solid tumors; and BNT141 and BNT142 to treat multiple solid tumors. In addition, the company develops RiboCytokines, which include BNT151, BNT152, and BNT152 for multiple solid tumors; chimeric antigen receptor T cell immunotherapies, such as BNT211 to treat multiple solid tumors, and BNT212 for pancreatic and other cancers; and checkpoint immunomodulators consisting of GEN1046 and GEN1042, which are in Phase I/II a clinical trial to treat multiple solid tumors. Further, it develops MVT-5873, an IgG1 monoclonal antibody, which is in Phase I/II clinical trial for pancreatic cancer; BNT411, small molecule immunomodulator product candidate for solid tumors; and infectious disease immunotherapies and rare disease protein replacement therapies. The company has collaborations with Genentech, Inc.; Sanofi S.A.; Genmab A/S; Genevant Sciences GmbH; Eli Lilly and Company; Bayer AG; Pfizer Inc.; Shanghai Fosun Pharmaceutical (Group) Co., Ltd.; Regeneron Pharmaceuticals, Inc.; and InstaDeep Ltd. The company was founded in 2008 and is headquartered in Mainz, Germany.

open in yahoo | open in reuters | open in google

Upgrade your FINVIZ experience